TipRanks
TipRanksTop Financial ExpertsInsidersAlbert Cha

Albert Cha Insider Profile

4 Followers
Albert Cha, Chief Executive Officer, Director, Ten Percent Owner at Frazier Life Sciences Acquisition Corp. II Class A, holds 300.00K shares in Frazier Life Sciences Acquisition Corp. II Class A (Ticker: FLSC), holds 0.00 shares in KalVista Pharmaceuticals (Ticker: KALV), holds ― shares in Aclaris Therapeutics (Ticker: ACRS). Most recently, Albert Cha Bought ― shares of Frazier Life Sciences Acquisition Corp. II Class A on Oct 15, 2026 for an estimated value of $3.00M.
See the Hottest Stocks Based on Insider Trading >
tipranks
Albert Cha

Albert Cha
Frazier Life Sciences Acquisition Corp. II Class A (FLSC)
Chief Executive Officer, Director, Ten Percent Owner

Ranked #99,277 out of 109,287 Corporate Insiders

Profitable Transactions

13%
1 out of 8 Profitable Transactions

Average Return

-31.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$83M
96.30%
3.70%
0.00%
A breakdown of Albert Cha's holdings
See the Top Stocks by Insiders

Insider Roles

Yarrow Bioscience
(YARW)
Director
Frazier Life Sciences Acquisition Corp. II Class A
(FLSC)
Chief Executive Officer, Director, Ten Percent Owner
Aclaris Therapeutics
(ACRS)
Director
Roles that Albert Cha holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
KalVista Pharmaceuticals
(KALV)
Rating:Informative Buy
Date:Nov 03, 2020 - Nov 03, 2021
Return:+7.30%
The most profitable trade made by Albert Cha
See the Latest Stocks Traded by Insiders

Albert Cha's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
FLSC
Frazier Life Sciences Acquisition Corp. II Class A
Oct 15, 2026
Chief Executive Officer, Director, Ten Percent Owner
Informative Buy
3.00M
$3.08M
KALV
KalVista Pharmaceuticals
Sep 13, 2023
―
Informative Sell
189.00K
$0.00
ACRS
Aclaris Therapeutics
―
Director
―
―
YARW
Yarrow Bioscience
Jan 29, 2018
Director
Uninformative Buy
―
$80.22M
~BHVN
Biohaven Pharmaceutical Holding Co
Mar 15, 2018
―
Uninformative Buy
2.00M
$311.12M
ALBO
Albireo Pharma
―
―
―
$68.59M
List of latest transactions for each holding click on a transaction to see Albert Cha's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Albert Cha insider profile FAQ

What is the percentage of profitable transactions made by Albert Cha?
The percentage of profitable transactions made by Albert Cha is 13%.
    What is the average return per transaction made by Albert Cha?
    The average return per transaction made by Albert Cha is -31.00%.
      What stocks does Albert Cha hold?
      Albert Cha holds: FLSC, KALV, ACRS, YARW, ~BHVN, ALBO stocks.
        What was Albert Cha’s latest transaction?
        Albert Cha latest transaction was an Informative Buy of $3.00M.
          What was Albert Cha's most profitable transaction?
          Albert Cha’s most profitable transaction was an Informative Buy of KALV stock on November 3, 2020. The return on the trade was 7.30%.
            What is Albert Cha's role in Frazier Life Sciences Acquisition Corp. II Class A?
            Albert Cha's role in Frazier Life Sciences Acquisition Corp. II Class A is Chief Executive Officer, Director, Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.